Vitiligo - Pipeline Review, Q2 2011 by GlobalMarketsDirect

VIEWS: 3 PAGES: 36

More Info
									Vitiligo – Pipeline Review, Q2 2011




                               Vitiligo - Pipeline Review, Q2 2011
                                                                                          Reference Code: GMDHC1084IDB

                                                                                          Publication Date: April 2011




Vitiligo – Pipeline Review, Q2 2011                                                                           GMDHC1084IDB / Pub April 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                             Page(1)
Vitiligo – Pipeline Review, Q2 2011



Ta b le o f Co n te n ts
Table of Contents                                                                                                2
List of Tables                                                                                                   4
List of Figures                                                                                                  5
Introduction                                                                                                     6
    Global Markets Direct Report Coverage                                                                        6
Vitiligo Overview                                                                                                7
Therapeutics Development                                                                                         8
    An Overview of Pipeline Products for Vitiligo                                                                8
Vitiligo Therapeutics under Development by Companies                                                            10
Vitiligo Therapeutics under Investigation by Universities/Institutes                                            11
Late Stage Products                                                                                             12
    Comparative Analysis                                                                                        12
Mid Clinical Stage Products                                                                                     13
    Comparative Analysis                                                                                        13
Pre-Clinical Stage Products                                                                                     14
    Comparative Analysis                                                                                        14
Vitiligo Therapeutics - Products under Development by Companies                                                 15
Vitiligo Therapeutics - Products under Investigation by Universities/Institutes                                 16
Companies Involved in Vitiligo Therapeutics Development                                                         17
    Clinuvel Pharmaceuticals Limited                                                                            17
    SWITCH Biotech LLC                                                                                          17
Vitiligo - Therapeutics Assessment                                                                              18
    Assessment by Monotherapy Products                                                                          18
    Assessment by Combination Products                                                                          19
    Assessment by Route of Administration                                                                       20
    Assessment by Molecule Type                                                                                 22
Drug Profiles                                                                                                   24
    Scenesse - Drug Profile                                                                                     24
         Product Description                                                                                    24
         Mechanism of Action                                                                                    24
         R&D Progress                                                                                           24
    SWT05104 - Drug Profile                                                                                     26
         Product Description                                                                                    26
         Mechanism of Action                                                                                    26
         R&D Progress                                                                                           26
    SWT05105 - Drug Profile                                                                                     27
         Product Description                                                                                    27
         Mechanism of Action                                                                                    27
         R&D Progress                                                                                           27
    VAL-003 - Drug Profile                                                                                      28
         Product Description                                                                                    28
         Mechanism of Action                                                                                    28
         R&D Progress                                                                                           28
    Autologous Transplantation of Melanocytes - Drug Profile                                                    29
         Product Description                                                                                    29
         Mechanism of Action                                                                                    29
         R&D Progress                                                                                           29


Vitiligo – Pipeline Review, Q2 2011                                                       GMDHC1084IDB / Pub April 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                        Page(2)
Vitiligo – Pipeline Review, Q2 2011


    Etanercept - Drug Profile                                                                                   30
         Product Description                                                                                    30
         Mechanism of Action                                                                                    30
         R&D Progress                                                                                           30
    Tacrolimus Ointment + TL01 - Drug Profile                                                                   31
         Product Description                                                                                    31
         Mechanism of Action                                                                                    31
         R&D Progress                                                                                           31
    Autologus Melanocytes + PUVA Therapy - Drug Profile                                                         32
         Product Description                                                                                    32
         Mechanism of Action                                                                                    32
         R&D Progress                                                                                           32
    Melanocyte-Keratinocyte Transplantation - Drug Profile                                                      33
         Product Description                                                                                    33
         Mechanism of Action                                                                                    33
         R&D Progress                                                                                           33
Vitiligo Therapeutics – Drug Profile Updates                                                                    34
Appendix                                                                                                        35
    Methodology                                                                                                 35
         Coverage                                                                                               35
         Secondary Research                                                                                     35
         Primary Research                                                                                       35
         Expert Panel Validation                                                                                36
    Contact Us                                                                                                  36
    Disclaimer                                                                                                  36




Vitiligo – Pipeline Review, Q2 2011                                                       GMDHC1084IDB / Pub April 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                        Page(3)
Vitiligo – Pipeline Review, Q2 2011




Lis t o f Ta b le s
Number of Products Under Development for Vitiligo, Q2 2011                                                       8

Products under Development for Vitiligo – Comparative Analysis, Q2 2011                                          9

Number of Products under Development by Companies, Q2 2011                                                      10

Number of Products under Investigation by Universities/Institutes, Q2 2011                                      11

Comparative Analysis by Late Stage Development, Q2 2011                                                         12

Comparative Analysis by Mid Clinical Stage Development, Q2 2011                                                 13

Comparative Analysis by Pre-Clinical Stage Development, Q2 2011                                                 14

Products under 
								
To top